Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study

BACKGROUND: The recombinant vesicular stomatitis virus (rVSV) vaccine expressing the Zaire Ebola virus (ZEBOV) glycoprotein is efficacious in the weeks following single-dose injection, but duration of immunity is unknown. We aimed to assess antibody persistence at 1 and 2 years in volunteers who rec...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Lancet Infect Dis
Main Authors: Huttner, Angela, Agnandji, Selidji Todagbe, Combescure, Christophe, Fernandes, José F, Bache, Emmanuel Bache, Kabwende, Lumeka, Ndungu, Francis Maina, Brosnahan, Jessica, Monath, Thomas P, Lemaître, Barbara, Grillet, Stéphane, Botto, Miriam, Engler, Olivier, Portmann, Jasmine, Siegrist, Denise, Bejon, Philip, Silvera, Peter, Kremsner, Peter, Siegrist, Claire-Anne
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6408946/
https://ncbi.nlm.nih.gov/pubmed/29627147
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1473-3099(18)30165-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados